These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT. Paternain A, García-Velloso MJ, Rosales JJ, Ezponda A, Soriano I, Elorz M, Rodríguez-Otero P, Aquerreta JD. Eur J Radiol; 2020 Dec; 133():109403. PubMed ID: 33202373 [Abstract] [Full Text] [Related]
63. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M. Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [Abstract] [Full Text] [Related]
64. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients. Sawicki LM, Grueneisen J, Buchbender C, Schaarschmidt BM, Gomez B, Ruhlmann V, Wetter A, Umutlu L, Antoch G, Heusch P. J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715 [Abstract] [Full Text] [Related]
68. Journal Club: Diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer. Miyake KK, Nakamoto Y, Kanao S, Tanaka S, Sugie T, Mikami Y, Toi M, Togashi K. AJR Am J Roentgenol; 2014 Aug; 203(2):272-9. PubMed ID: 25055259 [Abstract] [Full Text] [Related]
69. Correlation between tissue metabolism and cellularity assessed by standardized uptake value and apparent diffusion coefficient in peritoneal metastasis. Yu X, Lee EY, Lai V, Chan Q. J Magn Reson Imaging; 2014 Jul; 40(1):99-105. PubMed ID: 24170710 [Abstract] [Full Text] [Related]
70. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC). Bernstine H, Domachevsky L, Nidam M, Goldberg N, Abadi-Korek I, Shpilberg O, Groshar D. Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631 [Abstract] [Full Text] [Related]
71. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients. Ohno Y, Yui M, Yamamoto K, Takenaka D, Koyama H, Nagata H, Ueda T, Ikeda H, Ozawa Y, Toyama H, Yoshikawa T. J Magn Reson Imaging; 2023 Jul; 58(1):174-186. PubMed ID: 36971493 [Abstract] [Full Text] [Related]
72. Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient. Kong E, Chun KA, Cho IH. PLoS One; 2017 Jul; 12(7):e0180184. PubMed ID: 28672016 [Abstract] [Full Text] [Related]
73. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S. Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700 [Abstract] [Full Text] [Related]
74. Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer. Lai AYT, Perucho JAU, Xu X, Hui ES, Lee EYP. BMC Cancer; 2017 Dec 06; 17(1):825. PubMed ID: 29207964 [Abstract] [Full Text] [Related]
75. Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation. Choi YJ, Lee JH, Kim HO, Kim DY, Yoon RG, Cho SH, Koh MJ, Kim N, Kim SY, Baek JH. Radiology; 2016 Jan 06; 278(1):146-55. PubMed ID: 26115452 [Abstract] [Full Text] [Related]
76. Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes: Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT. Cerny M, Dunet V, Prior JO, Hahnloser D, Wagner AD, Meuli RA, Schmidt S. Clin Nucl Med; 2016 Apr 06; 41(4):289-95. PubMed ID: 26828149 [Abstract] [Full Text] [Related]
77. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. J Thorac Oncol; 2008 Apr 06; 3(4):358-64. PubMed ID: 18379353 [Abstract] [Full Text] [Related]
78. Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI. Theruvath AJ, Siedek F, Muehe AM, Garcia-Diaz J, Kirchner J, Martin O, Link MP, Spunt S, Pribnow A, Rosenberg J, Herrmann K, Gatidis S, Schäfer JF, Moseley M, Umutlu L, Daldrup-Link HE. Radiology; 2020 Jul 06; 296(1):143-151. PubMed ID: 32368961 [No Abstract] [Full Text] [Related]
79. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers. Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Simonitsch-Klupp I, Raderer M, Mayerhoefer ME. Acad Radiol; 2018 Apr 06; 25(4):453-460. PubMed ID: 29199055 [Abstract] [Full Text] [Related]
80. Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer. Choi JH, Lim I, Noh WC, Kim HA, Seong MK, Jang S, Seol H, Moon H, Byun BH, Kim BI, Choi CW, Lim SM. Ann Nucl Med; 2018 Jul 06; 32(6):389-397. PubMed ID: 29797002 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]